LH - Company ID 0000920148
The table below shows LABORATORY CORP OF AMERICA HOLDINGS's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $3.54B | $3.56B | $3.53B | $3.35B | $3.28B | $3.22B |
| Cost of revenue | $2.52B | $2.54B | $2.48B | $2.40B | $2.38B | $2.29B |
| Gross profit | $1.01B | $1.03B | $1.05B | $948.00M | $904.40M | $926.40M |
| R&D | - | - | - | - | - | - |
LABORATORY CORP OF AMERICA HOLDINGS reported annual revenue of $13.95B for fiscal year 2025. That is up 7.2% from $13.01B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.55B (FY 2016) to $13.95B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $551.00M |
| $552.40M |
| $579.30M |
| $546.00M |
| $568.60M |
| $557.80M |
| Operating income | $380.80M | $396.60M | $394.50M | $326.00M | $254.10M | $294.80M |
| Income tax | $41.70M | $75.50M | $66.40M | $62.20M | $41.00M | $62.10M |
| Net income | $277.80M | $261.10M | $237.90M | $212.80M | $169.30M | $205.30M |
| EPS (diluted) | $3.35 | $3.12 | $2.84 | $2.52 | $2.00 | $2.43 |